Global HEK293 Cell Line Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global HEK293 Cell Line Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

According to our (Global Info Research) latest study, the global HEK293 Cell Line market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Increasing demand for HEK293 cell lines, development of biomedical research technologies, clinical applications of cell therapy and gene therapy, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth of the HEK293 cell line market revenue.

The HEK293 cell line is a permanent line established from primary embryonic human kidney, which was transformed with sheared human adenovirus type 5 DNA. The adenoviral genes expressed in this cell line allow the cells to produce very high levels of recombinant proteins.

Due to the multiple copies of adenovirus E1A and E1B genes, HEK293 cells have a high transfection efficiency. This makes them useful in biotechnology, especially protein expression, gene therapy and vaccine production.



The pharmaceutical industry uses HEK293 cells for high-throughput screening assays because they can be transfected with plasmids encoding drug targets and grown in large numbers.



In industrial biotechnology, HEK293 cells are used to produce recombinant proteins and enzymes and to develop biosensors. Toxicology researchers, on the other hand, use HEK293 cells to study the effects of chemicals and environmental toxins on cellular processes and gene expression.



HEK293 cells are also used to produce recombinant viruses, such as adenoviruses and lentiviruses, for gene therapy, viral replication, and host-virus interactions.



Overall, the HEK293 cell line is versatile and can be used in biomedical research with applications in biotechnology, pharmaceuticals, and toxicology.

This report is a detailed and comprehensive analysis for global HEK293 Cell Line market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global HEK293 Cell Line market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global HEK293 Cell Line market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global HEK293 Cell Line market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global HEK293 Cell Line market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for HEK293 Cell Line

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global HEK293 Cell Line market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Altogen Biosystems, ATCC, Synthego, CLS and Thermo Fisher Scientific, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

HEK293 Cell Line market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
293T
293H
293E
293F
293S
293SGGD
Others

Market segment by Application
Protein Production
Receptor Signal Transduction
Drug Testing
Cancer Research
Others

Major players covered
Altogen Biosystems
ATCC
Synthego
CLS
Thermo Fisher Scientific
Beckman Coulter
Sigma Aldrich
Sartorius
Promega
Kerafast
Biocompare
InvivoGen
Innoprot
Takara
Henan Punuoyi Biological
Porton Pharma Solutions
Ubigene Biosciences

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe HEK293 Cell Line product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of HEK293 Cell Line, with price, sales, revenue and global market share of HEK293 Cell Line from 2018 to 2023.

Chapter 3, the HEK293 Cell Line competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the HEK293 Cell Line breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HEK293 Cell Line market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of HEK293 Cell Line.

Chapter 14 and 15, to describe HEK293 Cell Line sales channel, distributors, customers, research findings and conclusion.